Page 7,045«..1020..7,0447,0457,0467,047..7,0507,060..»

Influencing stem cell fate: New screening method helps scientists identify key information rapidly

Posted: Published on March 6th, 2012

Researchers can use the method, called nanocombinatorics, to build enormous libraries of physical structures varying in size from a few nanometers to many micrometers for addressing problems within and outside biology. Those in the fields of chemistry, materials engineering and nanotechnology could use this invaluable tool to assess which chemical and physical structures -- including size, shape and composition -- work best for a desired process or function. Nanocombinatorics holds promise for screening catalysts for energy conversion, understanding properties conferred by nanostructures, identifying active molecules for drug discovery or even optimizing materials for tissue regeneration, among other applications. Details of the method and proof of concept is published in the Proceedings of the National Academy of Sciences. "With further development, researchers might be able to use this approach to prepare cells of any lineage on command," said Chad A. Mirkin, who led the work. "Insight into such a process is important for understanding cancer development and for developing novel cancer treatment methodologies." Mirkin is the George B. Rathmann Professor of Chemistry in the Weinberg College of Arts and Sciences and professor of medicine, chemical and biological engineering, biomedical engineering and materials science and engineering. He also is the director of … Continue reading

Posted in Cell Medicine | Comments Off on Influencing stem cell fate: New screening method helps scientists identify key information rapidly

Research and Markets: Evolutionary Biology: Cell-Cell Communication and Complex Disease

Posted: Published on March 6th, 2012

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/e8a0ce/evolutionary_biolo) has announced the addition of John Wiley and Sons Ltd's new book "Evolutionary Biology: Cell-Cell Communication and Complex Disease" to their offering. An Integrative View of the Evolution of Genetics and the Natural World: Even in this advanced age of genomics, the evolutionary process of unicellular and multicellular organisms is continually in debate. Evolutionary Biology, Cell-Cell Communication, and Complex Disease challenges current wisdom by using physiology to present an integrative view of the nature, origins, and evolution of fundamental biological systems. Providing a deeper understanding of the way genes relate to the traits of living organisms, this book offers useful information applying evolutionary biology, functional genomics, and cell communication studies to complex disease. Examining the 4.5 billion-year evolution process from environment adaptations to cell-cell communication to communication of genetic information for reproduction, Evolutionary Biology hones in on the "why and how" of evolution by uniquely focusing on the cell as the smallest unit of biologic structure and function. Based on Empirically Derived Data Rather Than Association Studies, Evolutionary Biology Covers: Ambitious and game-changing Evolutionary Biology suggests that biology began as a mechanism for reducing energy within the cell, defying the Second Law of Thermodynamics. … Continue reading

Posted in Cell Medicine | Comments Off on Research and Markets: Evolutionary Biology: Cell-Cell Communication and Complex Disease

Influencing stem cell fate

Posted: Published on March 6th, 2012

Public release date: 6-Mar-2012 [ | E-mail | Share ] Contact: Megan Fellman fellman@northwestern.edu 847-491-3115 Northwestern University Northwestern University scientists have developed a powerful analytical method that they have used to direct stem cell differentiation. Out of millions of possibilities, they rapidly identified the chemical and physical structures that can cue stem cells to become osteocytes, cells found in mature bone. Researchers can use the method, called nanocombinatorics, to build enormous libraries of physical structures varying in size from a few nanometers to many micrometers for addressing problems within and outside biology. Those in the fields of chemistry, materials engineering and nanotechnology could use this invaluable tool to assess which chemical and physical structures -- including size, shape and composition -- work best for a desired process or function. Nanocombinatorics holds promise for screening catalysts for energy conversion, understanding properties conferred by nanostructures, identifying active molecules for drug discovery or even optimizing materials for tissue regeneration, among other applications. Details of the method and proof of concept is published in the Proceedings of the National Academy of Sciences. "With further development, researchers might be able to use this approach to prepare cells of any lineage on command," said Chad A. … Continue reading

Posted in Cell Medicine | Comments Off on Influencing stem cell fate

Nuvilex Forecasts Vast Partnership Opportunities Using Breakthrough Stem Cell Technology

Posted: Published on March 6th, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)-- Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, today pointed out the potential for substantial partnership and licensing opportunities using the companys cell encapsulation technology for applications in stem cell research and medicine. Migration of implanted cells away from the target site and host rejection have been recognized as fundamental challenges faced by the stem cell community regarding their use in therapy, which the companys technology overcomes. The technology being acquired from associate SG Austria is used to place live stem cells into strong, flexible and permeable capsules. These capsules can then be implanted into animals or humans for specific therapies. Stem cells can then exist at the desired location inside the capsules, prevented from migrating and protected from the immune system that aims to eliminate such foreign cells from the body. Stem cell therapy is being used by clinicians throughout the world for treating such diverse diseases as spinal cord injury, amyotrophic lateral sclerosis, burns, glioma, multiple myeloma, arthritis, heart disease, stroke, Stargardt's Macular Dystrophy, and age-related macular degeneration, among others, most of which can be found at ClinicalTrials.gov. Historically, researchers have faced numerous difficulties in succeeding with certain stem … Continue reading

Posted in Cell Therapy | Comments Off on Nuvilex Forecasts Vast Partnership Opportunities Using Breakthrough Stem Cell Technology

Pricey prescriptions

Posted: Published on March 6th, 2012

Grapevine is a sampling of comments and observations on a variety of timely topics submitted by readers of The Daily Times. I prefer "To have peace, prepare for peace." Usually, preparing for war leads to war. Grapevine comments suggest we "vote 'em out." I have tried to do that; however, when new politicians are voted in, they are just as greedy and likewise look out for themselves. There is no way we can know how politicians will act once they're in office. One thing I have found throughout my life is that it doesn't make much difference which party is in the majority -- we of the middle class are always taxed more and gain less. I just picked up a 90-day prescription for a strong antacid called Lansoprazole. The pharmacy said my insurance company saved me $322.19 and all I had to pay was $85.70. I assume the total cost of the drug was $407. I checked with a reputable online pharmacy and found you could buy the same drug, dose and amount for $42 --90 percent less, and 50 percent of my co-pay. This is one of the main reasons health care is so expensive. The drug companies, … Continue reading

Posted in Prescriptions | Comments Off on Pricey prescriptions

Chesterfield police warn residents of new drug

Posted: Published on March 6th, 2012

CHESTERFIELD, VA (WWBT) - The following is a press release from the Chesterfield County Police department. The Chesterfield County Police Department is urging residents to be aware of the dangers of a new designer drug, known as 25i, which has recently surfaced in the drug market. In Chesterfield County in recent weeks, seven people have gone to area hospitals with symptoms consistent with an overdose of 25i, a hallucinogen. In some of these cases, the patients have confirmed taking that drug. The side effects of any drug, including hallucinogens, may vary from person to person and often depend on many factors, including the person's size, weight and health, how much of the drug was taken, how it was taken and whether it was taken with or mixed with any other drug. The effects of a hallucinogenic drug can last for several hours and someone under the influence may exhibit some of these side effects: blurred vision; increased breathing rate; euphoria; hallucinations and distorted sensory processing, including visual, auditory, body, time and space; disorganized thoughts, confusion; anxiety, agitation, paranoia and feelings of panic; dizziness, impaired coordination; increased heart rate and blood pressure; increased body temperature and sweating, which may alternate with … Continue reading

Posted in Drug Side Effects | Comments Off on Chesterfield police warn residents of new drug

Appeals court allows Cardinal Health to sell controlled substances

Posted: Published on March 6th, 2012

By Amy Pavuk, Orlando Sentinel 12:48 p.m. EST, March 6, 2012 A federal appeals court has temporarily stopped the U.S. Drug Enforcement Administration from banning Cardinal Health, a prescription-drug wholesale distributor with a facility in Lakeland, from distributing controlled substances. The ruling is the latest of legal twists in the case against Cardinal, which distributes drugs to more than 2,500 pharmacies in the Southeast. DEA claims in court records that Cardinal Health has a history of problems and violated a memorandum of agreement the company made with the agency. In early February, DEA attempted to suspend Cardinal's license, but the company fought back. Cardinal Health sought a temporary restraining order against DEA, and a judge granted that request Feb. 3. But after hearing arguments in the case, which is being handled in the District of Columbia, a judge dissolved that temporary restraining order. The judge ruled last week that all orders for controlled substances, which include the highly addictive and powerful painkiller oxycodone, must be discontinued. Cardinal Health appealed that decision, and the U.S. Court of Appeals for the District of Columbia Circuit ruled Friday that the DEA's immediate suspension order be stayed pending further order of the court. Read … Continue reading

Posted in Wholesale Pharmacy | Comments Off on Appeals court allows Cardinal Health to sell controlled substances

Judge jails drugs gang for 18 years

Posted: Published on March 6th, 2012

Last updated at 13:25, Tuesday, 06 March 2012 FOUR men who transported drugs into South Cumbria from Merseyside have been jailed for a total of 18-and-a-half years. Title Author Copyright Description Preston Crown Court yesterday heard how Liverpool dealers Nicholas Flaherty and Kurtis Carney used a Furness address as a safe house for their drugs operation so they could more easily blend in with the local community. One of them used taxis to run around the streets and make deliveries. A dirty phone enabling contact between addicts and dealers was used by 36 Barrow addicts requesting a drugs sale. The pipeline of drugs to Barrow was serviced every four to five days during the period the conspiracy ran. Andrew Millington and Daniel Barclay, both of Barrow, were also convicted for their involvement in the drugs ring. The court was told that when an address in Lindal Street was searched, police discovered a machete under the doormat, a bag of knives in a kitchen cupboard and a shotgun cartridge on a kitchen worktop. See original here: Judge jails drugs gang for 18 years … Continue reading

Posted in Drugs | Comments Off on Judge jails drugs gang for 18 years

Research and Markets: China Asthmatic Prescription Drugs Sales Data 2006-2010: an essential resource for …

Posted: Published on March 6th, 2012

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/fa2356/china_asthmatic_pr) has announced the addition of the "China Asthmatic Prescription Drugs Sales Data 2006-2010" report to their offering. The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates of drug utilization in China are based on hospital drug prescription and drug purchasing data from extensive hospital coverage in 16 major cities and more than 300 hospitals. Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Xian, Shenyang, Harbin and Zhengzhou, covering significant percentages of all hospitals in these regions. Market shares from all major manufacturers including multinational and Chinese pharmaceutical companies and key products are analyzed systemically. The comprehensive prescription data in China will present you a clear picture of the competition landscape of Chinese drug market for each therapeutic area (such as cancer, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market. This series of China CPD reports have been indispensable references for all levels of decision makers … Continue reading

Posted in Drugs | Comments Off on Research and Markets: China Asthmatic Prescription Drugs Sales Data 2006-2010: an essential resource for …

Cigna Open To Selling Pharmacy-Benefit Manager Business (Again)

Posted: Published on March 6th, 2012

By Jon Kamp and David Benoit There has been some chatter lately that Cigna could potentially unload its pharmacy-benefit manager business, a move Cigna considered in 2009. Speaking at Cowen health-care conference,CEO David Cordani doesnt definitively say one way or the other, but he does say Cigna will remain open to structural alternatives that maximize shareholder value so long as they continue to enable me to deliver our promise to ourclients and customers. At the same time, he says this is an important business that is well performing based on a variety of measures. In 2009, there was a rash of consolidation discussions in the pharmacy-benefit manager business including Express Scriptss $4.68 billion deal for health-insurer WellPoints in-house pharmacy-benefit manager operations. Medco Health, Aetna and Cigna all talked up expectations. Aetna would eventually sign a contract to outsource its operations to CVS Caremark, but Cigna said it was sticking with its business. Flash forward to 2012 and the industry is again abuzz with consolidation talk as Express Scripts is waiting on regulatory approval for its nearly $30 billion deal for rival Medco Health. As Cigna closed its deal for medicare insurance company HealthSpring, which outsources its own pharmacy-benefits operations to … Continue reading

Posted in Pharmacy | Comments Off on Cigna Open To Selling Pharmacy-Benefit Manager Business (Again)

Page 7,045«..1020..7,0447,0457,0467,047..7,0507,060..»